Exam 3 randoms Flashcards
Biological response modulators
Cytokines: IL-2, Interferon alfa-2b
BCG
Aldesleukin
IL-2
Promotes prolif, diff, and recruit of T and B cells, NK cells, thymocytes
Used in metastatic melanoma and renal cell carc
AE: many, Capillary release syn
Absolutely no steorids.
IL-2 management of AEs
Cardiac: EKG, want electrolytes K>4, mag>2.
Oatmeal bath, lotions
N/V/D
Hold antiHTN except for beta blockers, give APAP or indometh for fever
Clindamycin prphy
Random crying: haloperidol or lorazepam
SOB: give oxygen
Increased SCr: fluids, start dopamine drip after 1.5 L
Interferon
Interferes with cell growth, diff, expression
PEG has much longer half life
Absolutely no steroids
Cause major depression and fatigue
Oncolytic Virus therapy
Nonvirulent herpes virus targets cancer cells and kill them
Talmigene laherparepvec
Talmigene laherparepvec
Reccurent melanoma, injected into lesions
Do NOT give acyclovir or other antivirals
Don’t touch site, dressing, body fluids for 1 week. Wear gloves if have to. Dispose of all used dressing and cleaning materials in sealed plastic bag before throwing away
Cancer vaccines
Sipuleucel-T
Own blood cells are taken out, incubated with PAP/GMCSF and reinjected into body to induce T-cell immunity
Sipuleucel-T
For metastatic castration resistant prostate cancer
DO NOT FILTER
Premeds with APAP and benedryl
Mild to moderate AEs
T cell therapies
CAR T cells Target CD19 (in A.L.L) Do NOT give growth factor Do NOT give steroids Cause cytokine release syndrome
FDA approved CAR T cell drugs
Tisagenlecleucel for A.L.L.
Axicabtagene ciloleucel for Large B Cell Lymphoma
Cytokine release syndrome
Premeds: APAP and Diphenhydramine Antibx at prodrome 1st line: O2, fluids, vasopressors, antipyretics 2nd line: Tocilizumab (IL-6 antagonist) 3rd line: rule out sepsis and adrenal insuff, maybe try steroids here 4th line: Tocilizumab 5th line: Siltuximab 6th line: cyclophos, ATG, alemtuzumab
Checkpoint inhibitors
Inhibit CTLA4 (Ipi), PD1 (Nivo or Pembro), or PDL1 Can un-mask cancer cells and let them be recognized by T-cells "release the breaks"
Pseudoprogession
initial growth in tumor size after initiation of checkpoint inhibitors
Side effects of checkpoint inh
Many organ systems Ipi has more AEs but Pembro and Nivo have more thyroid, fatigue, and arthralgia ok to use: STEROIDS Dermatitis Enterocolitis Hepatitis (must rule out others first) Hypophysitis--Ipi, fatigue and headache, need MRI Hypothyroidism-Pembro and Nivo Adrenal insuff Pneumonitis-can happen with all of these
Adrenal insuffieciency
Primary: gluco and mineralcorticoid, test both cortisol and ACTH. Tx with Hydrocortione po
Secondary: glucocorticoid only, don’t test ACTH. Tx with Fludrocortisone po
Life threatening, hypotension
CONSULT endocrinology
If steroids aren’t working in checkpoint inh side effects
Infliximab (not ok in hep)
po Budesonide for enterocolitis
When to permanently D/C immunotherpay
SJS, epidermal necrolysis Lifethreatening bowel perforation High AST or ALT or Tbili Life threatening hypophysitis or thyroid Pneumonitis requiring oxygen or adrenal insuff requiring hosp
Risk factors for cancer
Genetics
AGE
family history
Current breast cancer screening
Self breast exam: Optional
Clinical breast exam: part of periodic health exam
Mammogram: 40+ yearly
MRI: for BRCA mutation
Who is high risk, screening wise
BRCA mutation or relative with one Pedigree suggesting genetic predisp Lifetime risk>20% Radiation to chest between 10-30 years old Lobular carcinoma in situ Gail model of 1.7% in 35+ y/o Prior history of breast cancer
Mammography benefits
prevent metastasis
best benefit >50 y/o, decrease in mortality
Breast cancer prevention
Mastectomies decrease risk by 90%
Hystorectomy decrease by 50%
SERM therapy-raloxifen or tamoxifen
Aromatase inh-Exemestane (not FDA ap)
SERM risks
who gets it?
endometrial cancer, women over 50 Thromboembolism CV events (MI, stroke, TIA) Cataracts Hot flashes Vag discharge
Increased risk, >35 y/o, premen=tamox, post men=tamox/ralox/exemestane